FDA Approves New Formulation Of Migraine Headache Treatment
Today, there is good news for migraine sufferers. The United States Food and Drug Administration (FDA) recently approved a new formulation of Imitrex?(sumatriptan succinate) Injection. The new formulation gives people an easy way to take a 4mg dose of the product. With the push of a button, patients can treat their migraines quickly and easily using the Imitrex STATdose System? According to a study published in the journal Headache, 88 percent of patients found the product easy to use. In another study of patients with moderate to severe migraine pain, 67 percent reported headache relief within one hour and 11 percent of patients reported relief starting at 10 minutes.
“The availability of this product provides a simple and effective treatment option for patients who experience certain types of migraines,” said Robert Kaniecki, M.D., director of The Headache Center at the University of Pittsburgh and assistant professor of neurology. “Migraine patients who experience nausea or vomiting with their headaches often require an injection, since oral treatments are typically not well tolerated by these patients. Additionally, injections bypass the digestive system and enter the bloodstream quickly, which is especially important for treating certain migraine attacks, such as morning and rapidly escalating migraines.”
Kimberly McGonigle suffers from migraines. As a busy mother and professional, she knows first-hand that it is important to have options for treating migraine headaches. "I've suffered with migraines for the last 15 years and do not respond well to oral treatments due to the nausea I experience with each attack, so I use Imitrex Injection," said Kimberly. "With the injection, I can quickly and easily treat my migraines, so that I can get on with my life.”
Imitrex Injection is available in the easy-to-use STATdose System, which allows patients to administer a 4mg dose of the product with just the push of a button. Until now, patients did not have an easy way to administer doses lower than 6mg. The system includes two small, disposable cartridges pre-filled with a single dose of medicine and an easy-to-use autoinjector pen that allows patients to give themselves a single dose of the medication. The delivery system enables patients to treat their migraines quickly and conveniently while avoiding direct contact with a needle or a syringe.
The author is an Auckland plumber and he also offers tips for roof restoration and roof coatings.
Mail this post
Tags: FDA Approves New Formulation Of Migraine Headache Treatment
Leave a Reply